7 relations: Alzheimer's disease, AMPA receptor, Ampakine, Attention deficit hyperactivity disorder, Clinical trial, Food and Drug Administration, Glen Rock, New Jersey.
Alzheimer's disease
Alzheimer's disease (AD), also referred to simply as Alzheimer's, is a chronic neurodegenerative disease that usually starts slowly and worsens over time.
New!!: RespireRx and Alzheimer's disease · See more »
AMPA receptor
The α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor (also known as AMPA receptor, AMPAR, or quisqualate receptor) is an ionotropic transmembrane receptor for glutamate that mediates fast synaptic transmission in the central nervous system (CNS).
New!!: RespireRx and AMPA receptor · See more »
Ampakine
Ampakines, also stylized as AMPAkines, are a subgroup of AMPA receptor positive allosteric modulators with a benzamide or closely related chemical structure.
New!!: RespireRx and Ampakine · See more »
Attention deficit hyperactivity disorder
Attention-deficit hyperactivity disorder (ADHD) is a mental disorder of the neurodevelopmental type.
New!!: RespireRx and Attention deficit hyperactivity disorder · See more »
Clinical trial
Clinical trials are experiments or observations done in clinical research.
New!!: RespireRx and Clinical trial · See more »
Food and Drug Administration
The Food and Drug Administration (FDA or USFDA) is a federal agency of the United States Department of Health and Human Services, one of the United States federal executive departments.
New!!: RespireRx and Food and Drug Administration · See more »
Glen Rock, New Jersey
Glen Rock is a borough in Bergen County, New Jersey, United States.
New!!: RespireRx and Glen Rock, New Jersey · See more »
Redirects here:
Cortex Pharmaceuticals, Cortex Pharmaceuticals, Inc., RespireRx Pharmaceuticals.